Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Trends in Mortality Associated with Leukemias and Heart Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

CLL - 975

Trends in Mortality Associated with Leukemias and Heart Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

Anusha Kalluru

Poster Presenter: Anusha Kalluru

Thumbnail for Successful Treatment of CD19+ Mixed-Phenotype Acute Leukemia With Brexucabtagene Autoleucel Plus Tyrosine Kinase Inhibitor

CT - 976

Successful Treatment of CD19+ Mixed-Phenotype Acute Leukemia With Brexucabtagene Autoleucel Plus Tyrosine Kinase Inhibitor

Molly Gallogly

Poster Presenter: Molly Gallogly

Thumbnail for Survival Outcomes in Patients With Dual B-Cell and T-Cell Lymphoma Diagnoses

Previous 1...77 78 79 80 81 82 83...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

TCL - 977

Survival Outcomes in Patients With Dual B-Cell and T-Cell Lymphoma Diagnoses

Sami S Khaznadar

Poster Presenter: Sami S Khaznadar

Thumbnail for National Trends in Mortality Associated With Leukemias Complicated by Sepsis in U.S. Adults Aged =25 Years, 1999-2025

CLL - 978

National Trends in Mortality Associated With Leukemias Complicated by Sepsis in U.S. Adults Aged =25 Years, 1999-2025

Jasleen Kaur

Poster Presenter: Jasleen Kaur

Thumbnail for Epidemiologic Assessment of Risk Factors for Dual Diagnoses of B-Cell and T-Cell Lymphomas

TCL - 979

Epidemiologic Assessment of Risk Factors for Dual Diagnoses of B-Cell and T-Cell Lymphomas

Chiara A Hummel

Poster Presenter: Chiara A Hummel

Thumbnail for Efficacy and Safety of Anti-CD38 Monoclonal Antibody-Based Regimens in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 980

Efficacy and Safety of Anti-CD38 Monoclonal Antibody-Based Regimens in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

FNU Raja

Poster Presenter: Fnu Raja

$Thumbnail for Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis$

ABCL - 981

Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis

Maryam Maqsood

Poster Presenter: Maryam Maqsood

Thumbnail for Trends in Mortality Associated With Multiple Myeloma and Renal Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

MM - 982

Trends in Mortality Associated With Multiple Myeloma and Renal Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

Sumit Sharma

Poster Presenter: Sumit Sharma

$Thumbnail for Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial$

ABCL - 983

Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial

Nirav Shah

Poster Presenter: Nirav Shah

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors